Why We Still Need an HIV Vaccine After 45 Years
Scientists and advocates keep working toward a safe HIV vaccine. The fight is far from over.
It has been 45 years since the HIV epidemic began. Scientists are still searching for a safe HIV vaccine. This work is more important than ever.
HIV has deeply affected LGBTQ+ communities around the world. Gay and bisexual men are still among the most impacted groups. A vaccine could help protect millions of people. That is why researchers keep pushing forward.
Many different people are part of this effort. Scientists design and run the clinical trials. Community members volunteer to take part in these studies. Their participation is essential. Without volunteers, there is no research.
Community Advisory Boards, also called CABs, play a key role too. These boards include people from affected communities. They help guide the science in the right direction. Their voices make the research more relevant and trustworthy.
Advocates also play a crucial part. They fight for funding from governments and organisations. HIV research needs steady financial support. Without money, progress slows down or stops completely.
There are already good tools to prevent HIV today. PrEP is a daily pill that works very well. Condoms also provide strong protection. But these tools do not reach everyone. Some people face barriers like cost, stigma, or lack of access.
A vaccine would be different. Vaccines have ended or controlled many diseases in the past. Think of smallpox or polio. A successful HIV vaccine could do the same. It could protect people even without daily medication.
The road to a vaccine has not been easy. Several trials over the years have failed or shown limited results. But scientists have learned from each attempt. New technologies, like mRNA, are now offering fresh hope. The same technology helped create COVID-19 vaccines quickly.
The LGBTQ+ community has always been at the heart of the HIV movement. Activists in the 1980s demanded faster research and better care. That spirit of urgency lives on today. The goal remains clear: a safe and effective HIV vaccine for everyone.
The pursuit continues. And it matters now just as much as it ever did.